Tseng Ping-Tao, Chen Yen-Wen, Lin Pao-Yen, Tu Kun-Yu, Wang Hung-Yu, Cheng Yu-Shian, Chang Yi-Chung, Chang Chih-Hua, Chung Weilun, Wu Ching-Kuan
Department of Psychiatry, Tsyr-Huey Mental Hospital, Kaohsiung Jen-Ai's Home, Taiwan, No.509, Fengping 1st Rd., Daliao Dist, Kaohsiung City, 831, Taiwan.
Department of Neurology, E-Da Hospital, Kaohsiung, Taiwan.
BMC Psychiatry. 2016 Jan 26;16:16. doi: 10.1186/s12888-016-0718-8.
Music therapy (MT) has been used as adjunct therapy for schizophrenia for decades. However, its role is still inconclusive. A recent meta-analysis demonstrated that MT for schizophrenic patients only significantly benefits negative symptoms and mood symptoms rather than positive symptoms. In addition, the association between specific characteristics of MT and the treatment effect remains unclear. The aim of this study was to update the published data and to explore the role of music therapy in adjunct treatment in schizophrenia with a thorough meta-analysis.
We compared the treatment effect in schizophrenic patients with standard treatment who did and did not receive adjunct MT through a meta-analysis, and investigated the clinical characteristics of MT through meta-regression.
The main finding was that the treatment effect was significantly better in the patients who received adjunct MT than in those who did not, in negative symptoms, mood symptoms, and also positive symptoms (all p < 0.05). This significance did not change after dividing the patients into subgroups of different total duration of MT, amounts of sessions, or frequency of MT. Besides, the treatment effect on the general symptoms was significantly positively associated with the whole duration of illness, indicating that MT would be beneficial for schizophrenic patients with a chronic course.
Our meta-analysis highlights a significantly better treatment effect in schizophrenic patients who received MT than in those who did not, especially in those with a chronic course, regardless of the duration, frequency, or amounts of sessions of MT. These findings provide evidence that clinicians should apply MT for schizophrenic patients to alleviate disease severity.
几十年来,音乐疗法(MT)一直被用作精神分裂症的辅助治疗方法。然而,其作用仍不明确。最近的一项荟萃分析表明,针对精神分裂症患者的音乐疗法仅对阴性症状和情绪症状有显著益处,而非阳性症状。此外,音乐疗法的具体特征与治疗效果之间的关联仍不清楚。本研究的目的是更新已发表的数据,并通过全面的荟萃分析探讨音乐疗法在精神分裂症辅助治疗中的作用。
我们通过荟萃分析比较了接受和未接受辅助音乐疗法的精神分裂症患者在标准治疗中的治疗效果,并通过荟萃回归研究了音乐疗法的临床特征。
主要发现是,接受辅助音乐疗法的患者在阴性症状、情绪症状以及阳性症状方面的治疗效果明显优于未接受辅助音乐疗法的患者(所有p<0.05)。将患者分为音乐疗法总时长、疗程数或频率不同的亚组后,这一显著性并未改变。此外,对一般症状的治疗效果与疾病总病程显著正相关,这表明音乐疗法对病程较长的精神分裂症患者有益。
我们的荟萃分析强调,接受音乐疗法的精神分裂症患者的治疗效果明显优于未接受音乐疗法的患者,尤其是病程较长的患者,无论音乐疗法的时长、频率或疗程数如何。这些发现提供了证据,表明临床医生应将音乐疗法应用于精神分裂症患者以减轻疾病严重程度。